+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

  • PDF Icon

    Report

  • 158 Pages
  • February 2024
  • Region: Global
  • BCC Research
  • ID: 5941965
Description Jump to:

The Global Emerging Insulin Drug and Delivery Technologies Market was valued at $55.80 Billion in 2023 and is and is expected to reach $88.90 Billion in 2028, rising at a CAGR of 9.8%.

Report Scope

This report discusses the implications of the growing diabetes epidemic on the global and regional markets for emerging insulin drug and delivery technologies. It discusses companies in the relevant pharmaceutical and medical industries and provides profiles of the leading players as well as an update on M&A activity. The report’s patent analysis focuses on developments in Japan, Europe, and the U.S. Five-year global sales forecasts are provided for the major categories of insulin drug and delivery technologies and devices categories.

This report segments the global market into four regions:

  • North America.
  • Europe.
  • Asia-Pacific.
  • Rest of the World (RoW).

Report Includes

  • 57 data tables and 83 additional tables
  • An overview and industry analysis of the global markets for emerging insulin drug and delivery technologies, with an emphasis on plastic insulin syringes and vials
  • Analyses of the global market trends, with historical market revenue data (sales figures) for 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Estimate of the actual market size and revenue growth forecast, and a corresponding market share analysis by product type, application, and region
  • A look at the emerging technologies that have potential in the diabetes market, with improved glucose control, along with improved delivery methods
  • Examination of the current state of the insulin drug and delivery industry structure, focusing on technological updates and issues surrounding insulin pens and insulin syringes, ongoing research activities, and regulatory and pricing scenarios
  • Discussion of market dynamics, clinical trial applications, regulations, and penetration of technologies in the pharmaceutical and biotechnology markets
  • Discussion of the ESG developments and how they impact corporate performance, ratings and matrices, and consumer attitude, as well as the ESG practices of leading pharma and biotech companies
  • Review of the key patent grants/publications for insulin as a drug, along with its delivery methods
  • Analysis of the competitive landscape based on recent developments and segmental revenues of leading companies
  • Profiles of the leading market players

Table of Contents

Chapter 1 Introduction
  • Overview
  • Study Goals and Objectives
  • Reasons for Doing the Study
  • What's New in this Report?
  • Scope of Report
  • Information Sources
  • Methodology
  • Secondary Research
  • Geographic Breakdown
  • Segmentation Breakdown
Chapter 2 Summary and Highlights
  • Market Outlook
  • Market Summary
  • Developments and Trends
Chapter 3 Market Overview
  • Introduction
  • What is Diabetes?
  • Types of Diabetes
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes Mellitus or Hyperglycemia in Pregnancy
  • Impaired Glucose Tolerance and Impaired Fasting Glucose
  • Epidemiology of Diabetes
  • Gender Distribution
  • Regional Disparities
  • Market Dynamics Snapshot
  • Factors Affecting the Market
  • Market Drivers
  • Market Restraints
Chapter 4 Global Market for Emerging Insulin Drug and Delivery Technologies, by Type
  • Overview
  • Technological Advances in Insulin Syringes
  • Insulin Delivery Pen Devices
  • Disposable Insulin Pens
  • Reusable Insulin Pens
  • Technological Advances in Insulin Drug and Delivery Pen Devices
  • External Insulin Pumps
  • Technological Advances in Insulin Pump Systems
  • Implantable Insulin Pumps
  • Closed-Loop Artificial Pancreas
  • Bionic Pancreas
  • Smart Pens
Chapter 5 Global Market for Emerging Insulin Drug Delivery Devices, by Application
  • Overview
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes
Chapter 6 Global Market for Insulin Drug Delivery Devices, by Region
  • Overview
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
Chapter 7 Regulatory Landscape
  • Overview
  • U.S. Regulations for Insulin Drug and Delivery Technologies
  • European Regulations for Insulin Drug and Delivery Technologies
  • Japan's Regulations for Insulin Drug and Delivery Technologies
  • China's Regulations for Insulin Drug and Delivery Technologies
Chapter 8 Sustainability in the Insulin Drug and Delivery Market: An ESG Perspective
  • Introduction
  • ESG Performance Analysis
Chapter 9 Emerging Technologies
  • Introduction
  • Patient Outcomes Beyond Glucose Control
Chapter 10 Patent Analysis
  • Overview
Chapter 11 M&A and Venture Funding Outlook
  • M&A Analysis
Chapter 12 Competitive Landscape
  • Overview
Chapter 13 Company Profiles
  • AstraZeneca
  • B. Braun Se
  • BD
  • Cardinal Health
  • Debiotech Sa
  • Diabeloop Sa
  • Emperra Gmbh E-Health Technologies
  • Embecta Corp.
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corp.
  • Johnson & Johnson Services Inc.
  • Lifescan Ip Holdings Llc.
  • Lilly
  • Medtronic
  • Novo Nordisk A/S
  • Nugen Medical Devices
  • Owen Mumford Ltd.
  • Sanofi
  • Sooil Developments Co. Ltd.
  • Tandem Diabetes Care Inc.
  • Terumo Corp.
  • Ypsomed Ag
Chapter 14 Appendix
  • Government Regulatory Agencies and Professional Organizations
  • List of References
List of Tables
Summary Table: Global Market for Emerging Insulin Drug Delivery Devices, by Type, Through 2028
Table 1: Latest Data for Diabetes Globally, 2021 and 2045
Table 2: Global Estimates and Projections for Diabetes, 2019-2045
Table 3: Diabetes Cases, by Country, 2000-2045
Table 4: Age-Adjusted Comparative Prevalence of Diabetes, by Region, 2010-2045
Table 5: First-Time Generic Drug Approvals for Type 2 Diabetes, July 2022 to August 2022
Table 6: Global Market for Insulin Syringes and Vials, Through 2028
Table 7: Global Market for Insulin Syringes, by Type, Through 2028
Table 8: Leading Manufacturers of Insulin Syringes and Insulin Syringe Products, 2022
Table 9: Commercially Available Insulin Injector Pens
Table 10: Leading Manufacturers of External Insulin PumpsLeading Manufacturers of External Insulin Pumps
Table 11: Features of Current Leading Insulin Pump Systems
Table 12: Global Market for Emerging Insulin Drug Delivery Devices, by Type, Through 2028
Table 13: Global Market for Emerging Insulin Drug Delivery Devices, by Region, Through 2028
Table 14: Global Market for Insulin Syringes and Vials, by Region, Through 2028
Table 15: Global Market for Insulin Pens, by Region, Through 2028
Table 16: Global Market for Insulin Pumps, by Region, Through 2028
Table 17: Global Market for Smart Pens, by Region, Through 2028
Table 18: Global Market for Insulin Vials, by Region, Through 2028
Table 19: Global Market for Insulin Syringes, by Region, Through 2028
Table 20: Global Market for U-100 Insulin Syringes, by Region, Through 2028
Table 21: Global Market for U-40 Insulin Syringes, by Region, Through 2028
Table 22: Global Market for Emerging Insulin Drug Delivery Devices, by Application, Through 2028
Table 23: Global Market for Type 1 Diabetes, by Region, Through 2028
Table 24: Global Market for Type 2 Diabetes, by Region, Through 2028
Table 25: Global Market for Gestational Diabetes, by Region, Through 2028
Table 26: Global Market for Emerging Insulin Drug Delivery Devices, by Region, Through 2028
Table 27: North American Market for Insulin Drug Delivery Devices, by Country, Through 2028
Table 28: North American Market for Insulin Drug Delivery Devices, by Type, Through 2028
Table 29: North American Market for Insulin Syringes and Vials, by Segment, Through 2028
Table 30: North American Market for Insulin Syringes, by Type, Through 2028
Table 31: North American Market for Insulin Drug Delivery Devices, by Application, Through 2028
Table 32: European Market for Insulin Drug Delivery Devices, by Country, Through 2028
Table 33: European Market for Insulin Drug Delivery Devices, by Type, Through 2028
Table 34: European Market for Insulin Syringes and Vials, by Segment, Through 2028
Table 35: European Market for Insulin Syringes, by Type, Through 2028
Table 36: European Market for Insulin Drug Delivery Devices, by Application, Through 2028
Table 37: Asia-Pacific Market for Insulin Drug Delivery Devices, by Country, Through 2028
Table 38: Asia-Pacific Market for Insulin Drug Delivery Devices, by Type, Through 2028
Table 39: Asia-Pacific Market for Insulin Syringes and Vials, by Segment, Through 2028
Table 40: Asia-Pacific Market for Insulin Syringes, by Type, Through 2028
Table 41: Asia-Pacific Market for Insulin Drug Delivery Devices, by Application, Through 2028
Table 42: RoW Market for Insulin Drug Delivery Devices, by Sub-region, Through 2028
Table 43: RoW Market for Insulin Drug Delivery Devices, by Type, Through 2028
Table 44: RoW Market for Insulin Syringes and Vials, by Segment, Through 2028
Table 45: RoW Market for Insulin Syringes, by Type, Through 2028
Table 46: RoW Market for Insulin Drug Delivery Devices, by Application, Through 2028
Table 47: ESG Performance Analysis of the Market for Insulin Drug and Delivery Technologies
Table 48: Social Performance of the Market for Insulin Drug and Delivery Technologies
Table 49: Governance Performance of the Market for Insulin Drug and Delivery Technologies
Table 50: Clinical Trials Involving Insulin Drug and Delivery Technologies
Table 51: Clinical Trials Involving Artificial Pancreas, as of December 2023
Table 52: Approved Active Patents for Insulin Drug Delivery Devices, 2021-2023
Table 53: M&A in the Global Market for Insulin Drug Delivery Devices, 2021 to June 2023
Table 54: Recent Venture Funding for Insulin Drug Delivery Devices and Related Offerings
Table 55: Number of Deals for Insulin Drug and Delivery Technologies, by Status, January 2018 to September 2023
Table 56: Leading Manufacturers and Suppliers of Insulin Syringes and Vials
Table 57: Ranking of Insulin Syringe Manufacturers, by Market Share, 2022
Table 58: Ranking of Insulin Vial Manufacturers, by Market Share, 2022
Table 59: Global Market Ranking for Insulin Drug Delivery Devices, 2022
Table 60: AstraZeneca: Company Snapshot
Table 61: AstraZeneca: Financial Performance, FY 2022-2023
Table 62: AstraZeneca: Product Portfolio
Table 63: AstraZeneca: Key/Recent Developments, 2021-2023
Table 64: B. Braun SE: Company Snapshot
Table 65: B. Braun SE: Financials, FY 2021-2022
Table 66: B. Braun SE: Product Portfolio
Table 67: B. Braun SE: News/Key Developments, 2023
Table 68: BD: Company Snapshot
Table 69: BD: Financial Performance, FY 2022-2023
Table 70: BD: Product Portfolio
Table 71: BD: News/Key Developments, 2021-2023
Table 72: Cardinal Health: Company Snapshot
Table 73: Cardinal Health: Financial Performance, FY 2022-2023
Table 74: Cardinal Health: Product Portfolio
Table 75: Cardinal Health: News/Key Developments, 2021-2023
Table 76: Debiotech SA: Company Snapshot
Table 77: Debiotech SA: Product Portfolio
Table 78: Debiotech SA: News/Key Developments, 2022-2023
Table 79: Diabeloop SA: Company Snapshot
Table 80: Diabeloop SA: Product Portfolio
Table 81: Diabeloop SA: News/Key Developments, 2021-2023
Table 82: Emperra GmbH E-Health Technologies: Company Snapshot
Table 83: Emperra GmbH E-Health Technologies: Product Portfolio
Table 84: Emperra GmbH E-Health Technologies: News/Key Developments, 2022
Table 85: Embecta Corp.: Company Snapshot
Table 86: Embecta Corp.: Financial Performance, FY 2022-2023
Table 87: Embecta Corp.: Product Portfolio
Table 88: Embecta Corp.: News/Key Developments, 2021-2023
Table 89: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 90: F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022-2023
Table 91: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 92: Insulet Corp.: Company Snapshot
Table 93: Insulet Corp.: Financial Performance, FY 2022-2023
Table 94: Insulet Corp.: Product Portfolio
Table 95: Insulet Corp.: News/Key Developments, 2023
Table 96: Johnson & Johnson Services Inc.: Company Snapshot
Table 97: Johnson & Johnson Services Inc.: Financial Performance, FY 2022-2023
Table 98: Johnson & Johnson Services Inc.: Product Portfolio
Table 99: Johnson & Johnson Services Inc.: News/Key Developments, 2021-2023
Table 100: LifeScan IP Holdings LLC.: Company Snapshot
Table 101: LifeScan IP Holdings LLC.: Product Portfolio
Table 102: LifeScan IP Holdings LLC.: News/Key Developments, 2021
Table 103: Lilly: Company Snapshot
Table 104: Lilly: Financial Performance, FY 2022-2023
Table 105: Lilly: Product Portfolio
Table 106: Lilly: Recent Developments, 2021-2022
Table 107: Medtronic: Company Snapshot
Table 108: Medtronic: Financial Performance, FY 2022-2023
Table 109: Medtronic: Product Portfolio
Table 110: Medtronic: News/Key Developments, 2021-2023
Table 111: Novo Nordisk A/S: Company Snapshot
Table 112: Novo Nordisk A/S: Financial Performance, FY 2022-2023
Table 113: Novo Nordisk A/S: Product Portfolio
Table 114: Novo Nordisk A/S: Recent Developments, 2021-2023
Table 115: NuGen Medical Devices: Company Snapshot
Table 116: NuGen Medical Devices: Financial Performance, FY 2021-2022
Table 117: NuGen Medical Devices: Product Portfolio
Table 118: NuGen Medical Devices: News/Key Developments, 2022
Table 119: Owen Mumford Ltd.: Company Snapshot
Table 120: Owen Mumford Ltd.: Product Portfolio
Table 121: Sanofi: Company Snapshot
Table 122: Sanofi: Financial Performance, FY 2022-2023
Table 123: Sanofi: Product Portfolio
Table 124: Sanofi: Recent Developments, 2022-2023
Table 125: Sooil Developments Co. Ltd.: Company Snapshot
Table 126: Sooil Developments Co. Ltd.: Product Portfolio
Table 127: Tandem Diabetes Care Inc.: Company Snapshot
Table 128: Tandem Diabetes Care Inc.: Financial Performance, FY 2022-2023
Table 129: Tandem Diabetes Care Inc.: Product Portfolio
Table 130: Tandem Diabetes Care Inc.: News/Key Developments, 2023-2024
Table 131: Terumo Corp.: Company Snapshot
Table 132: Terumo Corp.: Financial Performance, FY 2021-2022
Table 133: Terumo Corp.: Product Portfolio
Table 134: Terumo Corp.: News/Key Developments, 2022
Table 135: Ypsomed AG: Company Snapshot
Table 136: Ypsomed AG: Financial Performance, FY 2021-2022
Table 137: Ypsomed AG: Product Portfolio
Table 138: Ypsomed AG: News/Key Developments, 2022-2023
Table 139: Government Regulatory Agencies and Professional Organizations

List of Figures
Summary Figure: Global Market for Emerging Insulin Drug Delivery Devices, by Type, 2020-2028
Figure 1: Market Dynamics for Emerging Insulin Drug and Delivery Technologies
Figure 2: Snapshot of the Worldwide Incidence of Diabetes, 2019-2045
Figure 3: AstraZeneca: Revenue Share, by Segment, 2023
Figure 4: AstraZeneca: Revenue Share, by Region/Country, 2023
Figure 5: B. Braun SE: Revenue Share, by Business Unit, FY 2022
Figure 6: B. Braun SE: Revenue Share, by Region/Country, FY 2022
Figure 7: BD: Revenue Share, by Business Unit, FY 2023
Figure 8: BD: Revenue Share, by Region/Country, FY 2023
Figure 9: Cardinal Health: Revenue Share, by Business Unit, FY 2023
Figure 10: Cardinal Health: Revenue Share, by Region/Country, FY 2023
Figure 11: Embecta Corp.: Revenue Share, by Region/Country, FY 2023
Figure 12: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 13: F. Hoffmann-La Roche Ltd.: Revenue Share, by Region/Country, FY 2023
Figure 14: Insulet Corp.: Revenue Share, by Business Unit, FY 2023
Figure 15: Insulet Corp.: Revenue Share, by Region/Country, FY 2023
Figure 16: Johnson & Johnson Services Inc.: Revenue Share, by Business Unit, FY 2023
Figure 17: Johnson & Johnson Services Inc.: Revenue Share, by Region/Country, FY 2023
Figure 18: Lilly: Revenue Share, by Product Type, FY 2023
Figure 19: Lilly: Revenue Share, by Region/Country, FY 2023
Figure 20: Medtronic: Revenue Share, by Business Unit, FY 2023
Figure 21: Medtronic: Revenue Share, by Region/Country, FY 2023
Figure 22: Novo Nordisk A/S: Revenue Share, by Business Unit, FY 2023
Figure 23: Novo Nordisk A/S: Revenue Share, by Region/Country, FY 2023
Figure 24: NuGen Medical Devices: Revenue Share, by Region, FY 2022
Figure 25: Sanofi: Revenue Share, by Business Segment, FY 2023
Figure 26: Sanofi: Revenue Share, by Region, 2023
Figure 27: Tandem Diabetes Care Inc.: Revenue Share, by Region/Country, FY 2023
Figure 28: Terumo Corp.: Revenue Share, by Business Unit, FY 2022
Figure 29: Terumo Corp.: Revenue Share, by Region/Country, FY 2022
Figure 30: Ypsomed AG: Revenue Share, by Business Unit, FY 2022
Figure 31: Ypsomed AG: Revenue Share, by Region/Country, FY 2022

Executive Summary

The analysis revealed that the fastest-growing market segment is smart pens, which is expected to grow at a predicted CAGR of 12.6% during the forecast period. The insulin syringes and vials segment is expected to have the slowest growth rate, a CAGR of 8.7%.

Reasons for Doing the Study:

The increase in prevalence of diabetes mellitus, including type 2 diabetes worldwide, the most prevalent form, has reached epidemic levels. Concurrently, instances of type 1 diabetes mellitus are on the rise, albeit to a lesser extent. These escalating trends raise significant alarm, impacting not only those affected but also governments and healthcare providers, as the economic ramifications of diabetes are substantial. They involve the direct burden of managing the disease and its common and often catastrophic complications, including cardiovascular disease, peripheral neuropathy and blindness.

Ensuring timely diagnosis of diabetes and delivering efficient treatment are priorities for governments and healthcare organizations. As the prevalence of diabetes continues to rise and diagnostic methods advance, the existing market for insulin drug and delivery technologies is expected to expand significantly. Consequently, diabetes holds substantial commercial importance for both the manufacturers of treatment drugs and the producers of monitoring devices.

For companies in this sector to strengthen their market position, they require precise and current evaluations of the present magnitude of the diabetes epidemic, as well as its probable trajectory over the upcoming five years, and the potential impact of insulin drug and delivery devices and technical developments now in the pipeline.

The market for insulin drug and delivery technologies will continue to grow significantly in many areas, notably regulatory compliance.

Companies Mentioned

  • AstraZeneca
  • B. Braun Se
  • BD
  • Cardinal Health
  • Debiotech Sa
  • Diabeloop Sa
  • Embecta Corp.
  • Emperra Gmbh E-Health Technologies
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corp.
  • Johnson & Johnson Services Inc.
  • Lifescan Ip Holdings Llc.
  • Lilly
  • Medtronic
  • Novo Nordisk A/S
  • Nugen Medical Devices
  • Owen Mumford Ltd.
  • Sanofi
  • Sooil Developments Co. Ltd.
  • Tandem Diabetes Care Inc.
  • Terumo Corp.
  • Ypsomed Ag

Table Information

Report AttributeDetails
No. of Pages158
PublishedFebruary 2024
Forecast Period2023 - 2028
Estimated Market Value ( USD ) in 2023 $ 55.8 Billion
Forecasted Market Value ( USD ) by 2028 $ 88.9 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Global Insulin Delivery Devices Market by Type (Insulin Pens [Reusable, Disposable], Insulin Pumps (Tethered, Tubeless), Insulin Syringes, Insulin Pen Needles (Standard, Safety)), End User (Hospitals & Clinics, Patients/Homecare) - Forecast to 2028 - Product Image

Global Insulin Delivery Devices Market by Type (Insulin Pens [Reusable, Disposable], Insulin Pumps (Tethered, Tubeless), Insulin Syringes, Insulin Pen Needles (Standard, Safety)), End User (Hospitals & Clinics, Patients/Homecare) - Forecast to 2028

  • Report
  • 230 Pages
  • Global
From
Insulin Delivery Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update - Product Image

Insulin Delivery Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • Report
  • 253 Pages
  • Global
From
Insulin Delivery Device - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 - Product Image

Insulin Delivery Device - Global Market Insights, Competitive Landscape, and Market Forecast - 2028

  • Report
  • 150 Pages
  • Global
From
Global Insulin Delivery Devices Market Outlook, 2028 - Product Image

Global Insulin Delivery Devices Market Outlook, 2028

  • Report
  • 190 Pages
  • Global
From
Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2024 - Product Image

Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.